Cancer treatment delays surge over decade, study finds waits now exceed 10 days longer

A decade of data tells a troubling story about how long Americans now wait to begin cancer treatment. Researchers analyzing records from more than two million patients diagnosed between 2012 and 2023 found that the gap between diagnosis and the start of treatment has stretched by more than ten days across six common cancers. The study, published in JAMA Surgery and conducted by teams at UCLA and Massachusetts General Hospital, tracked patients with early to locally advanced breast, colon, lung, pancreatic, stomach, and esophageal cancers who underwent surgery as part of their initial care.

The numbers are stark. Stomach cancer patients now wait 49 days on average before treatment begins, up from 35 days a decade ago. Lung cancer waits have climbed from 41 to 53 days. Breast cancer delays grew from 34 to 45 days. Colon cancer patients wait 31 days now, compared to 20 days in 2012. Pancreatic cancer waits increased from 23 to 32 days, and esophageal cancer from 38 to 48 days. The researchers measured the interval from diagnosis to either surgery or pre-surgical therapy designed to shrink tumors before the operating room. What stands out is not just the increase, but its consistency—every cancer type showed the same troubling pattern. The study also found that a growing proportion of patients now wait 60 days or longer to begin any treatment at all.

These delays are not distributed equally. Black patients face longer waits than white patients. People covered by Medicaid wait longer than those with private insurance. Patients in lower-income areas experience greater delays. Those who must travel farther to reach treatment centers wait longer still. Academic medical centers and high-volume hospitals, despite their resources and expertise, are associated with longer delays. The West region of the country showed longer wait times than other parts of the nation. For non-breast cancers, the adoption of robotic surgery technology correlated with extended delays, suggesting that the infrastructure and training required for newer techniques may be outpacing the system's capacity to deploy them smoothly.

Why this matters extends beyond inconvenience. Previous medical research has linked delays in surgical treatment to higher death rates and worse long-term survival outcomes. The longer a cancer patient waits after diagnosis, the worse their prognosis tends to be. Dr. Marc Siegel, Fox News's senior medical analyst, called the situation urgent. "This is part of our healthcare system that needs fixing immediately," he said, noting that even prestigious academic centers are struggling to move patients through the system quickly enough.

Two Stanford physicians who published commentary alongside the study offered a diagnosis of the underlying problem. As cancer care has become more specialized and regionalized over the past twenty years, efforts to improve quality may have inadvertently created bottlenecks. "As cancer care continues to regionalize, efforts to improve quality may inadvertently create barriers to timely treatment unless capacity and coordination evolve in parallel," they wrote. The implication is clear: the system has optimized for excellence in some dimensions while losing sight of speed in others.

The study does have limits. Because researchers relied on historical data from the National Cancer Database, they could not pinpoint exactly why individual patients experienced delays—whether due to scheduling problems, logistical obstacles, or patient preferences. The database also did not capture when patients first noticed symptoms or initially sought medical advice before receiving a formal diagnosis. Still, the scale of the data and the consistency of the findings across multiple cancer types and patient populations suggest the pattern is real and systemic. The question now is whether the healthcare system can address it before more patients experience the consequences of waiting.